| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.bplindia.in | |
| Financial Indicators | ||
|---|---|---|
| Market Cap | 214.81 Cr. | |
| Earnings per share (EPS) | 35.59 | Trailing Twelve Months Ending 2021-03 |
| Price-Earning Ratio (PE) | 10.53 | Trailing Twelve Months Ending 2021-03 |
| Industry PE | 35.25 | Trailing Twelve Months Ending 2021-03 |
| Book Value / Share | 251.01 | Trailing Twelve Months Ending 2021-03 |
| Price to Book Value | 1.49 | Calculated using Price: 374.90 |
| Dividend Yield | 0.00 | Period Ending 2020-03 |
| No. of Shares Subscribed | 0.57 Cr. | 5,729,666 Shares |
| FaceValue | 10 | |
| Company Profile | ||
|
Bharat Parenterals was formed under the chairmanship of Ramesh Desai and incorporated as limited company on September 3, 1992. The company has grown steadily from a humble beginning, to a position of strength under the stewardship of Bharat R. Desai, a visionary whose untiring patience, perseverance & unflinching commitment has resulted in the growth of the company. He has effectively combined his tact & talent, business acumen & professional experience in the pharmaceutical field to bring the company in the forefront of contract manufacturing units in Gujarat. Besides, the company has established its own range of products in domestic & international markets. The company has added a feather in the cap by setting up a dedicated facility for antiretroviral drugs to its existing facility of general & B-Iactum group of drugs. The company has established its own range of products in domestic & international markets. Its main vision is commited to become a major pharmaceutical company catering to domestic and international market by manufacturing and marketing high quality Pharmaceutical Formulation meeting all customer & regulatory requirements. Business area of the company: The company is engaged in to the business of the Pharmaceuticals & Drugs. Products: GENERAL: - Tablets - Capsules - Injections - Oral Liquids - Dry Syrups - External Preparations - ENT - Sachets - Granules LACTAM: - Tablets - Capsules - Injections - Dry Syrups CEPHALOSPORINS: - Tablets - Capsules - Injections - Dry Syrups - Sachets ANTIRETROVIRAL: - Tablets - Capsules - Oral Liquids VETERINARY: - Tablets - Injections - Oral Liquids - Semi Solids Subsidiaries: Varenyam (A division of Bharat Parenterals). The company was formed under the chairmanship of Mr. Bharat Desai and incorporated as Private Limited company on 9th July 2016. |
||
Company Profile
Bharat Parenterals was formed under the chairmanship of Ramesh Desai and incorporated as limited company on September 3, 1992. The company has grown steadily from a humble beginning, to a position of strength under the stewardship of Bharat R. Desai, a visionary whose untiring patience, perseverance & unflinching commitment has resulted in the growth of the company. He has effectively combined his tact & talent, business acumen & professional experience in the pharmaceutical field to bring the company in the forefront of contract manufacturing units in Gujarat. Besides, the company has established its own range of products in domestic & international markets. The company has added a feather in the cap by setting up a dedicated facility for antiretroviral drugs to its existing facility of general & B-Iactum group of drugs.
The company has established its own range of products in domestic & international markets. Its main vision is commited to become a major pharmaceutical company catering to domestic and international market by manufacturing and marketing high quality Pharmaceutical Formulation meeting all customer & regulatory requirements.
Business area of the company:
The company is engaged in to the business of the Pharmaceuticals & Drugs.
Products:
GENERAL:
- Tablets
- Capsules
- Injections
- Oral Liquids
- Dry Syrups
- External Preparations
- ENT
- Sachets
- Granules
LACTAM:
- Tablets
- Capsules
- Injections
- Dry Syrups
CEPHALOSPORINS:
- Tablets
- Capsules
- Injections
- Dry Syrups
- Sachets
ANTIRETROVIRAL:
- Tablets
- Capsules
- Oral Liquids
VETERINARY:
- Tablets
- Injections
- Oral Liquids
- Semi Solids
Subsidiaries:
Varenyam (A division of Bharat Parenterals).
The company was formed under the chairmanship of Mr. Bharat Desai and incorporated as Private Limited company on 9th July 2016.
| 1 Day |
|
+1.30% |
| 1 Week |
|
-0.11% |
| 1 Month |
|
+1.41% |
| 3 Month |
|
-8.15% |
| 6 Month |
|
-0.39% |
| 1 Year |
|
-10.71% |
| 2 Year |
|
+105.76% |
| 5 Year |
|
| 5 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | |
| Return on Equity (%) | 11.38 | 11.45 | 13.35 | 25.47 | 22.76 | |
| Return on Capital Employed (%) | 14.23 | 11.47 | 18.10 | 39.30 | 30.83 | |
| Return on Assets (%) | 5.37 | 5.99 | 7.61 | 14.71 | 13.94 |
| Particulars | 5 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Shh. Funds | 57 | 64 | 73 | 94 | 118 | |
| Non Curr. Liab. | 7 | 3 | 0 | 4 | 3 | |
| Curr. Liab. | 56 | 43 | 57 | 61 | 66 | |
| Minority Int. | ||||||
| Equity & Liab. | 120 | 110 | 130 | 159 | 188 | |
| Non Curr. Assets | 49 | 46 | 39 | 41 | 56 | |
| Curr. Assets | 72 | 64 | 91 | 118 | 132 | |
| Misc. Exp. not W/O | ||||||
| Total Assets | 120 | 110 | 130 | 159 | 188 |
| Particulars | 5 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Net Sales | 124 | 111 | 137 | 220 | 228 | |
| Other Income | 5 | 8 | 7 | 13 | 12 | |
| Total Income | 129 | 119 | 144 | 232 | 240 | |
| Total Expenditure | -114 | -105 | -124 | -191 | -201 | |
| PBIDT | 15 | 14 | 19 | 42 | 40 | |
| Interest | -1 | -1 | -1 | -1 | -1 | |
| Depreciation | -4 | -6 | -6 | -6 | -6 | |
| Taxation | -3 | -1 | -4 | -13 | -9 | |
| Exceptional Items | ||||||
| PAT | 6 | 7 | 9 | 21 | 24 |
| Particulars | 5 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Cash Fr. Operatn. | -2 | 6 | 20 | 14 | ||
| Cash Fr. Inv. | -2 | -8 | -9 | -13 | ||
| Cash Fr. Finan. | -8 | 4 | -4 | -3 | ||
| Net Change | -11 | 2 | 7 | -1 | ||
| Cash & Cash Eqvt | 2 | 4 | 11 | 10 |
|
Sat, 24 Jul 2021
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we bring to your kind attention that the Company/RTA has received a request from the shareholder regarding loss of her Share certificates. In this regard Adroit Corporate Services Private Limited RTA of company has verified the details and had informed the shareholder the necessary procedure for issue of duplicate share certificates. After receipt of valid documents the Share certificates will be issued within the statutory time limit. |
||||||||||||||
|
Mon, 19 Jul 2021
Shareholding for the Period Ended June 30 2021 Bharat Parenterals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here |
||||||||||||||
|
Mon, 12 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021
|
| Mon, 26 Jul 2021 |
Stock Underperforming Benchmark Index in both 1 Week and 3 Month
|
Stock Underperforming Sectoral Index in both 1 Week and 3 Month
|
Strongly Underperforming Benchmark index
|
Strongly Underperforming Sectoral index
|
Both SRS And ARS Below Zero
|
Equities
M.F.
Sectors